<p>BioRestorative Therapies, Inc.（OTCMKTS:BRTXQ - 獲取免費報告）的股票在週二交易中下跌了 2.7%。該公司的股價最低曾達到$1.0550，最後交易價為$1.08。在午盤交易中，共交易了 26,495 股，較平均交易量 62,169,492 股下降了 100%。該股票此前收盤價為$1.11。</p>
<h2>BioRestorative Therapies 股票下跌 2.7%</h2>
<p>該公司的五十日移動平均價為$1.40，二百日移動平均價為$1.53。該公司的市值為 17.7 億美元，市盈率為-1.01，貝塔值為 102.36。</p>
<h2>關於 BioRestorative Therapies</h2>
<p>(獲取免費報告)</p>
<p>BioRestorative Therapies, Inc.開發使用細胞和組織協議的治療產品，主要涉及成人幹細胞。該公司的兩個核心項目與椎間盤/脊柱疾病和代謝紊亂的治療相關。其椎間盤/脊柱項目包括一個主要的細胞治療候選藥物 BRTX-100，該產品由從患者骨髓中收集的自體（或個人自身）培養的間充質幹細胞製成，旨在非手術治療疼痛的腰骶椎間盤疾病。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，而不是 BioRestorative Therapies</li>
<li>3 只超市股票證明它們仍然是必需品</li>
<li>消費者得到了煤炭，但聖誕老人給這兩家零售商帶來了巨大的收益</li>
<li>股票評級和推薦：理解分析師評級</li>
<li>10 倍收益？這三隻機器人股票可能在 2035 年前爆發</li>
<li>什麼是 MarketRank™？如何使用它</li>
<li>安海斯 - 布希收購 BeatBox 以贏得年輕飲酒者</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 BioRestorative Therapies 嗎？</h2>
<p>在考慮 BioRestorative Therapies 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買……而 BioRestorative Therapies 並不在名單上。</p>
<p>雖然 BioRestorative Therapies 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

BRTX

<p>BioRestorative Therapies (OTCMKTS:BRTXQ) 的股價下跌了 2.7%，至 1.08 美元，交易量顯著低於平均水平。該股票的五十日移動平均線為 1.40 美元，二百日移動平均線為 1.53 美元。分析師目前對該股票的評級為持有，但建議其他股票可能是更好的投資選擇</p>

<p>Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - Get Free Report) traded down 2.7% during trading on Tuesday . The company traded as low as $1.0550 and last traded at $1.08. 26,495 shares were traded during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.11.</p>
<div class="lb-trans"><p>BioRestorative Therapies, Inc.（OTCMKTS:BRTXQ - 獲取免費報告）的股票在週二交易中下跌了 2.7%。該公司的股價最低曾達到$1.0550，最後交易價為$1.08。在午盤交易中，共交易了 26,495 股，較平均交易量 62,169,492 股下降了 100%。該股票此前收盤價為$1.11。</p>
</div><h2>BioRestorative Therapies Stock Down 2.7%</h2>
<div class="lb-trans"><h2>BioRestorative Therapies 股票下跌 2.7%</h2>
</div><p>The firm's fifty day moving average is $1.40 and its two-hundred day moving average is $1.53. The firm has a market cap of $1.77 billion, a P/E ratio of -1.01 and a beta of 102.36.</p>
<div class="lb-trans"><p>該公司的五十日移動平均價為$1.40，二百日移動平均價為$1.53。該公司的市值為 17.7 億美元，市盈率為-1.01，貝塔值為 102.36。</p>
</div><h2>About BioRestorative Therapies</h2>
<div class="lb-trans"><h2>關於 BioRestorative Therapies</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.</p>
<div class="lb-trans"><p>BioRestorative Therapies, Inc.開發使用細胞和組織協議的治療產品，主要涉及成人幹細胞。該公司的兩個核心項目與椎間盤/脊柱疾病和代謝紊亂的治療相關。其椎間盤/脊柱項目包括一個主要的細胞治療候選藥物 BRTX-100，該產品由從患者骨髓中收集的自體（或個人自身）培養的間充質幹細胞製成，旨在非手術治療疼痛的腰骶椎間盤疾病。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than BioRestorative Therapies</li>
<li>3 Grocery Stocks That Are Proving They Are Still Essential</li>
<li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li>
<li>Stock Ratings and Recommendations: Understanding Analyst Ratings</li>
<li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li>
<li>What is MarketRank™? How to Use it</li>
<li>Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 BioRestorative Therapies</li>
<li>3 只超市股票證明它們仍然是必需品</li>
<li>消費者得到了煤炭，但聖誕老人給這兩家零售商帶來了巨大的收益</li>
<li>股票評級和推薦：理解分析師評級</li>
<li>10 倍收益？這三隻機器人股票可能在 2035 年前爆發</li>
<li>什麼是 MarketRank™？如何使用它</li>
<li>安海斯 - 布希收購 BeatBox 以贏得年輕飲酒者</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in BioRestorative Therapies Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 BioRestorative Therapies 嗎？</h2>
</div><p>Before you consider BioRestorative Therapies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 BioRestorative Therapies 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRestorative Therapies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前進行購買……而 BioRestorative Therapies 並不在名單上。</p>
</div><p>While BioRestorative Therapies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 BioRestorative Therapies 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

BioRestorative Therapies (OTCMKTS:BRTXQ) 的股價下跌了 2.7% - 現在是賣出的時候嗎？